文献速递慢性肾脏病肾血管病与高血压肾小球疾病

TonEBP介导高血糖诱导的炎症及血管与肾脏损伤

Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury.
PubMed 文献 · J Am Soc Nephrol · 2017-11-20

研究在高血糖背景下探讨TonEBP在巨噬细胞中的作用及其与糖尿病肾病(DN)的关系。小鼠模型中TonEBP单倍剂量不足可减少高血糖诱导的巨噬细胞活化、肾脏巨噬细胞浸润及促炎基因表达,减轻DN。健康人群队列中TonEBP遗传变异与肾功能、血压及全身炎症相关。

要点

  • TonEBP单倍剂量不足减轻高血糖诱导的肾脏炎症和DN。
  • TonEBP遗传变异与人类肾功能、血压和全身炎症相关。
  • TonEBP可能是减轻糖尿病相关炎症和肾血管损伤的靶点。

核心结论

  • TonEBP介导高血糖诱导的促炎激活和慢性肾脏炎症,促进DN和CKD发生。

研究设计与样本

  • 研究包括DN小鼠模型和健康人群队列,检测TonEBP单倍剂量不足对高血糖诱导巨噬细胞活化的影响及人类TonEBP遗传变异与表型的关联。

主要发现

  • 在DN小鼠模型中,与野生型相比,TonEBP单倍剂量不足减少高血糖诱导的巨噬细胞活化、肾脏巨噬细胞数量、促炎基因表达并减轻DN。
  • 在健康人群队列中,TonEBP遗传变异与肾功能、血压和全身炎症相关,其中一个与肾功能相关的变异在大型人群队列中重复验证。

临床怎么用

  • TonEBP可作为减轻糖尿病和应激诱导炎症及肾血管损伤的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic nephropathy (DN) has become the single leading cause of ESRD in developed nations. Bearing in mind the paucity of effective treatment for DN and progressive CKD, novel targets for treatment are sorely needed. We previously reported that increased activity of tonicity-responsive enhancer-binding protein (TonEBP) in monocytes was associated with early DN in humans. We now extend these findings by testing the hypotheses that TonEBP in macrophages promotes hyperglycemia-mediated proinflammatory activation and chronic renal inflammation leading to DN and CKD, and TonEBP genetic variability in humans is associated with inflammatory, renal, and vascular function-related phenotypes. In a mouse model of DN, compared with the wild-type phenotype, TonEBP haplodeficiency associated with reduced activation of macrophages by hyperglycemia, fewer macrophages in the kidney, lower renal expression of proinflammatory genes, and attenuated DN. Furthermore, in a cohort of healthy humans, genetic variants within TonEBP associated with renal function, BP, and systemic inflammation. One of the genetic variants associated with renal function was replicated in a large population-based cohort. These findings suggest that TonEBP is a promising target for minimizing diabetes- and stress-induced inflammation and renovascular injury.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Choi SY, Lim SW, Salimi S, et al. Tonicity-Responsive Enhancer-Binding Protein Mediates Hyperglycemia-Induced Inflammation and Vascular and Renal Injury. J Am Soc Nephrol. 2017. PMID: 29158465. doi:10.1681/ASN.2017070718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。